U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are “getting away with murder” in what they charge the government for medicines, and promised that would change.
After his remarks, the Ishares Nasdaq Biotech ETF dropped 4 percent at its session low and was on track for its largest daily percentage drop since late June. Trump has blasted other industries for charging the government too much, particularly defense companies Lockheed Martin Corp and Boeing Co, but has made only a few public statements about drug pricing since being elected.
After his promise during a news conference, the ARCA pharmaceutical index fell 2 percent as Pfizer Inc gave up 2.6 percent and Johnson & Johnson fell 1 percent. Biotech Gilead Sciences Inc fell 2.3 percent.
The drug industry has been on edge for two years about the potential for more government pressure on pricing after sharp increases in the costs of some life-saving drugs drew scrutiny in the press and among lawmakers. The government is investigating Medicaid and Medicare overspending on Mylan NV’s allergy treatment EpiPen, for instance.
Trump’s campaign platform included allowing the Medicare healthcare program to negotiate with pharmaceutical companies, which the law currently prohibits, and he has also discussed making it easier to import drugs at cheaper prices.
“We are going to start bidding. We are going to save billions of dollars over time,” Trump said.
Medicare, which covers more than 55 million elderly or disabled Americans, spends hundreds of billions of dollars on drugs every year.
Industry trade group Pharmaceutical Research and Manufacturers of America did not have an immediate comment.
Daniel O’Day, CEO of Roche Pharmaceuticals, a division of Roche Holding AG, said in an interview on the sidelines of the JP Morgan Healthcare conference in San Francisco that the company focuses on innovation and investing in research.
Price increases over the past several years have been “responsible” and in the range of low to mid single digits, he said.
(Reporting by Caroline Humer in New York, and Deena Beasley in San Francisco; Editing by Chizu Nomiyama and David Gregorio)
Rod Rosenstein secretly crippled the Mueller investigation: report
According to a report from the New York Times, former Deputy Attorney General Rod Rosenstein had a hand in limiting the scope of special counsel Robert Mueller's investigation into ties between Donald Trump's 2016 campaign and the Russians by secretly curtailing an FBI counterintelligence probe.
The report from Michael Schmidt of the Times begins by stating, "The Justice Department secretly took steps in 2017 to narrow the investigation into Russian election interference and any links to the Trump campaign, according to former law enforcement officials," before adding, "But law enforcement officials never fully investigated Mr. Trump’s own relationship with Russia, even though some career F.B.I. counterintelligence investigators thought his ties posed such a national security threat that they took the extraordinary step of opening an inquiry into them."
‘Meanest and most disrespectful’ senator: Trump lashes out at Kamala Harris in latest presser
At Tuesday's White House press conference, President Donald Trump spent a considerable portion of the time attacking Sen. Kamala Harris (D-CA), who was just announced to be former Vice President Joe Biden's running mate.
Harris, complained Trump, was the "meanest and most disrespectful person in the U.S. Senate." He particularly dwelled on her sharp interrogation of Brett Kavanaugh during his Supreme Court hearings.
Trump also added that she "lied" about a number of issues, claimed repeatedly she wants to raise taxes, said she is for "open borders and sanctuary cities ... which is also protecting a large number of criminals," and that she would destroy the Second Amendment.
California bill to establish nation’s second public bank applauded as ‘historic challenge to Wall Street domination’
"If California is serious about addressing racial and income inequities, we must create a banking system that centers people not profits."
In a move advocacy groups celebrated as a "historic challenge to Wall Street domination of municipal finances," a pair of California state lawmakers on Thursday unveiled legislation that would establish the nation's second publicly-owned bank and empower the institution to lend to businesses and local governments fighting to stay afloat amid the Covid-19 pandemic.